SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.87+1.3%3:40 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (8340)1/17/1999 8:26:00 PM
From: Bluegreen  Read Replies (1) of 17367
 
Anybody want to talk about what a great job the FDA does on efficacy of chemotherapy? Should the approval of a drug to fight Meningo. be any different? Do we really know the true efficacy of any product until it has been in the real world for sometimes years or decades? When was the true efficacy and wide usage in many different settings of thiazide diuretics discovered? Don't know what a thiazide diuretic is? How about aspirin? Now talk about discovered efficacy even after its very long initial history. Who would of guessed at all its uses in modern days. Ideal situation would be to have cheap small efficacy studies done but approval just on safety issues only. That way decision is between patient and clinician. Number one prescribed antidepressant in Germany is St. Johns Wort not Prozac or its siblings and cousins. Also in my world anybody involved in the approval process would be required to have a vast amount of direct patient care experience. Indeed, if someone is deciding efficacy, let them have the experience of signing death certificates and long term patient care in a variety of settings. Remember what the Ivory Tower pontificates now as fact, will surely change in the future. You can take that to the bank.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News